AME vs MRK · P/E 30, rev $2.04B vs P/E 33, rev $16.61B
Ametek Inc (AME) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
AME currently screens at market cap $42.11B and trailing P/E 29.9. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the AME and MRK stock pages for the full models.
Not investment advice.